-
B329430-1mgBicyclomycin is a polar metabolite first isolated from|Streptomyces sapporonensis|in 1972. Bicyclomycin is a selective Gram negative profile of bicyclomycin is rare among Streptomyces metabolites. The primary site of action for bicyclomycin is
-
B329430-50mgBicyclomycin is a polar metabolite first isolated from|Streptomyces sapporonensis|in 1972. Bicyclomycin is a selective Gram negative profile of bicyclomycin is rare among Streptomyces metabolites. The primary site of action for bicyclomycin is
-
B329430-5mgBicyclomycin is a polar metabolite first isolated from|Streptomyces sapporonensis|in 1972. Bicyclomycin is a selective Gram negative profile of bicyclomycin is rare among Streptomyces metabolites. The primary site of action for bicyclomycin is
-
B334658-10mgBicyclomycin benzoate is a polar metabolite first isolated from Streptomyces sapporonensis in 1972 with activity against Gram negative bacteria. The selective Gram negative profile of Bicyclomycin benzoate is rare among Streptomyces metabolites, and
-
B334658-25mgBicyclomycin benzoate is a polar metabolite first isolated from Streptomyces sapporonensis in 1972 with activity against Gram negative bacteria. The selective Gram negative profile of Bicyclomycin benzoate is rare among Streptomyces metabolites, and
-
B334658-50mgBicyclomycin benzoate is a polar metabolite first isolated from Streptomyces sapporonensis in 1972 with activity against Gram negative bacteria. The selective Gram negative profile of Bicyclomycin benzoate is rare among Streptomyces metabolites, and
-
B334658-5mgBicyclomycin benzoate is a polar metabolite first isolated from Streptomyces sapporonensis in 1972 with activity against Gram negative bacteria. The selective Gram negative profile of Bicyclomycin benzoate is rare among Streptomyces metabolites, and
-
B339211-5mgBiotinamidocaproate Tobramycin Amide.
-
B339203-5mgBiotinyl tobramycin amide.
-
B329372-500μgBischloroanthrabenzoxocinone ((-)BABX) is a selective inhibitor of Type II fatty acid synthesis (FASII). BABX showed IC|50|values of 11.4 and 35.3 μg/ml in the S. aureus and E. coli FASII assays, respectively, with comparable antibacterial
-
-
B329642-1mgBlasticidin A, an antibiotic produced by Streptomyces, has been shown to have strong inhibitory activity toward aflatoxin production by|Aspergillus parasiticus|. This inhibition of aflatoxin production does not have a strong growth suppressing